TREMFYA® is the first FDA-approved medication of its kind to selectively block IL-23 for adults with moderate to severe plaque psoriasis.
Sign up here to get TREMFYA® news and information delivered to your inbox.
Are you ready to look into a new treatment for your moderate to severe plaque psoriasis? Let’s get you started! Sign up now for your personalized TREMFYA® Welcome Experience to make sure you have everything you need to know about TREMFYA® to help you and your doctor make the best choice for your treatment. Remember, you got this.
AGREE TO TREMFYA® INFORMATION TERMS AND CONDITIONS